RAP, INC. Ending HIV in DC (EH-DC) - RAP, INC

Will implement ending HIV in DC (EH-DC), a comprehensive program to increase access to substance use disorder (SUD) and CO-occurring SUD and mental health disorder (COD) treatment integrated with HIV prevention and treatment for 90 adults (450 individuals over 5 years) aged 18 years and older, living with or at risk of HIV in washington, D.C. (a US HIV priority area). The project will address D.C.'s unmet SUD/ COD treatment needs and reduce one of the highest HIV rates in the nation. The population of focus is residents of washington, D.C., aged 18 years and older, engaged in evidence-based treatment for SUD or COD who are at risk for or living with HIV/ aids. RAP will prioritize adults that comprise the majority of new and existing HIV diagnoses in D.C., including black and latino adults, men who have SEX with men, members of the lgbtq+ community, injection drug users, and adult men and women who are living with or at risk of HIV and/ or viral hepatitis. RAP will place special emphasis on engaging and treating racial/ ethnic underserved populations who are disproportionately affected by HIV/ aids and viral hepatitis in D.C. To reduce the impact of behavioral health challenges, reduce risk and incidence of HIV, and increase access to treatment for those at highest risk. Interventions: EH-DC includes an interconnected design of services to create a seamless transition at various stages of readiness to enter SUD treatment, related medical treatment, and related case management and recovery support services. Consistent with the CDC's ending the HIV epidemic (EHE) initiative and its four pillars, RAP's activities will be focused on the rapid diagnosis, treatment, prevention, and response to HIV using proven interventions. In addition to providing evidence-based SUD/ COD treatment, including FDA-approved mat, RAP will employ a multidisciplinary care team responsible for staging recovery-oriented, trauma-informed, and behavioral health equity-based interventions. Both in-house and via referral, RAP will provide rapid and confirmatory HIV and hepatitis testing for all admissions, treatment for HIV and viral hepatitis, prep and PEP services, peer support, education, case management, and linkage to follow-up care. With a focus on equity, services will be accessible by people with limited english proficiency, veterans, and lbgtq+ individuals. Measureable goals: the overarching goal is to reduce SUD, cods, HIV/aids and other related problems among racial/ ethnic minority adults. Goal 1: increase access to and retention in treatment for behavioral health diagnoses-- at least 80% of clients will complete prescribed treatment/ services. Goal 2: reduce new HIV and viral hepatitis infections-- reduce client substance use, especially injection drug use by 75%. Goal 3: improve outcomes for behavioral health clients at risk of or living with HIV-- at least 65% of clients will experience improved CJ, SUD, MH, housing, educational, medical/ health, social connectedness, or employment. Goal 4: increase recovery support services-- retain a minimum of 70% of participants in aftercare/ recovery support services for at least six (6) months. Goal 5: increase linkage to HIV/ hepatitis medical care-- at least 75% of HIV and/ or HEP-positive participants will adhere to both behavioral and medical treatment.